NKGen Biotech, Inc. Warrants
NKGNW
NKGNW was delisted on the 4th of March, 2025.
31 hedge funds and large institutions have $198K invested in NKGen Biotech, Inc. Warrants in 2023 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 2 closing their positions.
500% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 2
48% more funds holding
Funds holding: 21 → 31 (+10)
77% less capital invested
Capital invested by funds: $875K → $198K (-$676K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$13.5K |
| 2 |
KL
KIM LLC
Wichita,
Kansas
|
+$12.4K |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$8.09K |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$7.08K |
| 5 |
Walleye Capital
New York
|
+$7.05K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
-$59.2K |
| 2 |
BI
Bulldog Investors
Saddle Brook,
New Jersey
|
-$7.89K |
| 3 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$3.71K |
| 4 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$708 |
| 5 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$270 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GCIA
26
Gabelli & Co Investment Advisers
Rye,
New York
| $1.39K | +$2.33K | +17,240 | New |
|
|
GF
27
Gabelli Funds
Rye,
New York
| $1.39K | +$2.32K | +17,221 | New |
|
28
UBS Group
Zurich,
Switzerland
| $1.1K | -$31 | -230 | -2% |
|
|
CL
29
CSS LLC
Chicago,
Illinois
| $1.03K | +$1.73K | +12,795 | New |
|
|
PI
30
PEAK6 Investments
Chicago,
Illinois
| $892 | – | – | – |
|
|
CCM
31
CAAS Capital Management
New York
| $808 | +$1.35K | +10,000 | New |
|
|
CS
32
Clear Street
New York
| $40 | – | – | – |
|
|
33
BNP Paribas Financial Markets
Paris,
France
| – | -$59.2K | -150,000 | Closed |
|
|
BI
34
Bulldog Investors
Saddle Brook,
New Jersey
| – | -$7.89K | -20,000 | Closed |
|
NKGNW Hedge Fund Activity: Q4 2023 in Review
31 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in NKGen Biotech, Inc. Warrants (NKGNW) for Q4 2023, worth a combined $198K — down 77% from $875K a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new NKGNW positions and 2 closed out — a net gain of 10 holders — while 0 added to existing stakes and 5 trimmed.
The largest buyer was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, opening a new position worth an estimated $13.5K. The largest seller was BNP Paribas Financial Markets, exiting entirely with an estimated $59.2K sold.
- 31 institutional investors held NKGen Biotech, Inc. Warrants (NKGNW) as of Q4 2023, up from 21 in Q3 2023.
- Funds reported $198K of NKGen Biotech, Inc. Warrants stock for Q4 2023, down 77% quarter-over-quarter.
- 12 funds opened new NKGen Biotech, Inc. Warrants positions in Q4 2023 and 2 closed out, a net change of +10 holders.
- The largest NKGen Biotech, Inc. Warrants buyer in Q4 2023 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $13.5K added.
- The largest NKGen Biotech, Inc. Warrants seller in Q4 2023 was BNP Paribas Financial Markets, an estimated $59.2K sold.
Based on aggregated 13F filings for Q4 2023.